newsfilter
← Latest News
GlobeNewswire·

Registration Now Open For Tribe Public's Webinar Event "Exploring the Neuroprotective Qualities of Rare Cannabinoids" Featuring InMed's Management Team On November 17, 2022

VANCOUVER, British Columbia, Nov. 10, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ:INM), a leader in the pharmaceutical research, development and manufacturing of rare